금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Japanese Yen: Intervention risks cap losses against US Dollar – OCBC
OCBC’s Sim Moh Siong and Christopher Wong highlight that September Bank of Japan (BoJ) hike odds hav...
Canadian Dollar: Data and tariffs shape near-term risks – TD Securities
TD Securities’ Robert Both and Emma Lawrence highlight that markets are watching Canadian CPI and po...
Is CAR Stock Worth Buying Despite Weak Liquidity and High Valuation?
Avis Budget's efficiency gains are lifting profits, but weak liquidity, high leverage and a premium valuation argue for patience.
Trex targets $2B in annual sales by 2030 as it accelerates Little Rock ramp and plans up to $150M in 2026 buybacks
AMD leads AI chip stocks higher ahead of Q2 results
Amazon.com Stock Is Cheaper Than The Market On Earnings And Pricier On Cash
Free cash flow is negative while the cloud build runs, and that is the whole question for anyone weighing the stock today.
Credo Technology Surges 52% YTD: Buy, Sell or Hold the Stock?
CRDO's 52% YTD surge reflects AI connectivity growth, but premium valuation, customer concentration and execution risks favor patience.
New Zealand GDT Price Index declined to 0.1% from previous 1.5%
Asia FX: Yen-led winners and export backdrop – MUFG
Michael Wan at MUFG explains that South Korean Won (KRW), Thai Baht (THB), Singapore Dollar (SGD) and, to a smaller extent, Philippine Peso (PHP) are the main Asian FX beneficiaries if Japanese Yen st ...
3 Huge Winners of the Q2 Earnings Season: BE, MSFT, EME
There have been several standouts in the cycle so far, including Microsoft, Bloom Energy, and EMCOR Group, all of which have seen nice momentum in the days following their robust earnings releases.
Senator Warren, other lawmakers probe six insurers amid rising insurance costs
MUEL Q2 Earnings Rise Y/Y Despite Margin Pressure, Backlog Strong
Paul Mueller's Q2 revenues jump 29% y/y, but lower margins weigh on earnings as strong pharmaceutical demand and a healthy backlog support the results.
SK Hynix receives multiple Buy ratings as financial firms initiate coverage
AdaptHealth projects $490M-$520M 2026 EBITDA amid portfolio reset and west coast contract headwinds